Patients should be informed when AI systems are used in clinical trials - Nature Medicine

Norge Nyheter Nyheter

Patients should be informed when AI systems are used in clinical trials - Nature Medicine
Norge Siste Nytt,Norge Overskrifter
  • 📰 NatureMedicine
  • ⏱ Reading Time:
  • 15 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 9%
  • Publisher: 53%

Patients should be informed when artificial intelligence AI systems are used in clinical trials. Correspondence from dbittermanmd and colleagues BrighamWomens DanaFarber

Artificial intelligence systems are increasingly being investigated in clinical trials. Trials that use AI must be held to the same ethical standards for risk assessment and disclosure as all human participant studies.

All clinical AI systems, especially those under active investigation, have new risks, including human–machine interactions, interpretability and data limitations. The full magnitude and scope of these risks is not yet known because clinical AI integration is still in its infancy.

Vi har oppsummert denne nyheten slik at du kan lese den raskt. Er du interessert i nyhetene kan du lese hele teksten her. Les mer:

NatureMedicine /  🏆 451. in US

Norge Siste Nytt, Norge Overskrifter

Similar News:Du kan også lese nyheter som ligner på denne som vi har samlet inn fra andre nyhetskilder.

AI-generated text may have a role in evidence-based medicine - Nature MedicineAI-generated text may have a role in evidence-based medicine - Nature MedicineAI-generated text, such as from chatGPT, may have a role in evidence-based medicine. Correspondence from pengyifan JFRousseau_MD Edward H. Shortliffe and nychunhua WCMPopHealthSci
Les mer »

The flash dance of midlife: the Skylight 1 trial - Nature MedicineThe flash dance of midlife: the Skylight 1 trial - Nature MedicineFor women who choose nonhormonal therapy for HotFlashes in menopause, fezolinetant is one of several modestly efficacious and safe options — but women want more. Read the News and Views from Andrea LaCroix and Kristine Ensrud. UMNews UCSanDiego
Les mer »

Oncolytic DNX-2401 virotherapy plus pembrolizumab in recurrent glioblastoma: a phase 1/2 trial - Nature MedicineOncolytic DNX-2401 virotherapy plus pembrolizumab in recurrent glioblastoma: a phase 1/2 trial - Nature MedicineA safety and efficacy trial of a single intratumoral dose of the oncolytic adenovirus DNX-2401 followed by intravenous anti-PD-1 pembrolizumab in patients with recurrent glioblastoma shows an encouraging clinical benefit rate and 12 months overall survival.
Les mer »

How AI Will Change Medicine ForeverHow AI Will Change Medicine ForeverWith news that AI has helped discover a superbug-killing antibotic, let's take a look at some of the other ways we expect AI will impact medicine. How do YOU think AI will impact our health?
Les mer »

The People Who Make AI Keep Saying AI Will Destroy HumanityThe People Who Make AI Keep Saying AI Will Destroy HumanityThe last few weeks have seen an alarming trend of major players in AI warning that AGI has the potential to “wipe out humanity.”
Les mer »

Latest Generative AI Boldly Labeled As Constitutional AI Such As Claude By Anthropic Has Heart In The Right Place, Says AI Ethics And AI LawLatest Generative AI Boldly Labeled As Constitutional AI Such As Claude By Anthropic Has Heart In The Right Place, Says AI Ethics And AI LawLatest Generative AI Gallantly Labeled As Constitutional AI Such As Claude By Anthropic Has Heart In The Right Place, Says AI Ethics And AI Law
Les mer »



Render Time: 2025-03-05 21:49:53